Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450043 · ClinicalTrials.gov registry record · NA
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
A NA study, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04450043: Active NA study, sponsored by Massachusetts General Hospital.
NCT04450043 is a NA study that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04450043, a NA study, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This research study is designed to develop and test a new supportive care program to help individuals with lung cancer improve their quality of life after cancer treatment is over.
Primary Outcome
Feasibility will be assessed by calculating the proportions of potential participants enrolled (≥35%)
Interventions
- BEHAVIORAL Run-In Sessions 1-5
- BEHAVIORAL RCT Transitions Program Sessions 1-5
- BEHAVIORAL RCT Control Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT04450043 still lists
NCT04450043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Run-In Sessions 1-5 is the first listed.
NCT04450043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04450043 about?
NCT04450043 is a clinical study titled "The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance". This research study is designed to develop and test a new supportive care program to help individuals with lung cancer improve their quality of life after cancer treatment is over.
What is the current status of trial NCT04450043?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2020-08-01. Estimated completion is 2026-11-01.
What interventions are being tested in trial NCT04450043?
The interventions under investigation include: Run-In Sessions 1-5 (BEHAVIORAL), RCT Transitions Program Sessions 1-5 (BEHAVIORAL), RCT Control Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450043?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04450043's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI